These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33434077)

  • 1. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M
    Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
    Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing gastrointestinal cancer diagnostics: a systematic review and meta-analysis of circulating microRNA-1246 as a non-invasive biomarker.
    Aalami AH; Shahriari A; Mazaheri M; Aalami F; Sahebkar A
    Biomarkers; 2024 Jul; 29(5):233-243. PubMed ID: 38696280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Circulating Cell-free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-analysis.
    Aalami AH; Aalami F; Aliabadi EK; Amirabadi A; Sahebkar A
    Curr Med Chem; 2024; 31(22):3345-3359. PubMed ID: 37349993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis.
    Li G; Shen Q; Li C; Li D; Chen J; He M
    Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma.
    Huang JT; Liu SM; Ma H; Yang Y; Zhang X; Sun H; Zhang X; Xu J; Wang J
    J Cell Physiol; 2016 Feb; 231(2):328-35. PubMed ID: 26291451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis.
    Wang Y; Wang Q; Zhang N; Ma H; Gu Y; Tang H; Xu Z; Gao Y
    Tumour Biol; 2014 Nov; 35(11):11595-604. PubMed ID: 25135426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
    Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of miR-21 levels as potential biomarkers in the early diagnosis of hepatocellular carcinomaļ¼ša meta-analysis.
    Zhang H; Ding R; Chen D
    Biomarkers; 2021 Nov; 26(7):586-597. PubMed ID: 34266326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
    Xu L; Cai Y; Chen X; Zhu Y; Cai J
    BMC Cancer; 2021 Sep; 21(1):989. PubMed ID: 34479528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):11995-2004. PubMed ID: 25159040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric Cancer and Circulating microRNAs: An Updated Systematic Review and Diagnostic Meta-Analysis.
    Aalami AH; Aalami F; Sahebkar A
    Curr Med Chem; 2023; 30(33):3798-3814. PubMed ID: 36411580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.
    Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A
    PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
    Jiang L; Cheng Q; Zhang BH; Zhang MZ
    Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis.
    Huynh KQ; Le AT; Phan TT; Ho TT; Pho SP; Nguyen HT; Le BT; Nguyen TT; Nguyen ST
    Oxid Med Cell Longev; 2023; 2023():8379231. PubMed ID: 37122536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.